CON: Therapy for a Patient with Platinum-Resistant/Refractory Ovarian Cancer Should Not Be Selected Based on Results of an In Vitro Extreme Drug Sensitivity/Resistance Assay

CON: Therapy for a Patient with Platinum-Resistant/Refractory Ovarian Cancer Should Not Be Selected Based on Results of an In Vitro Extreme Drug Sensitivity/Resistance Assay

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Clinical Ovarian Cancer - Volume 2, Supplement, September 2009, Pages 26-30

John Farley, Michael J. Birrer,